Ingalls & Snyder LLC Immucell Corp Transaction History

Ingalls & Snyder LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 21, 2021	SELL	$5.98 - $11.88 $59,800 - $118,800	-10,000 Closed	0 $0
Q2 2020 Jul 31, 2020	SELL	$3.95 - $4.9 $347,698 - $431,322	-88,025 Reduced 89.8%	10,000 $47,000
Q1 2020 Apr 22, 2020	BUY	$3.79 - $5.92 $6,746 - $10,537	1,780 Added 1.85%	98,025 $372,000
Q4 2019 Jan 15, 2020	BUY	$4.81 - $5.57 $9 - $11	2 Added 0.0%	96,245 $496,000
Q2 2019 Jul 11, 2019	BUY	$5.89 - $6.86 $27,871 - $32,461	4,732 Added 5.17%	96,243 $626,000
Q3 2018 Oct 24, 2018	BUY	$6.5 - $8.99 $594,821 - $822,683	91,511 New	91,511 $762,000

1.15M

Ticker ICCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,746,860
Market Cap $30.2M
Description
ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive ...

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

Stay updated on Ingalls & Snyder LLC with notifications on news.